JW Pharmaceutical secures GLP-1 drug rights in $81m deal
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-04-09 18:45 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Asia, China, Drugs, Asia Pacific
--------------------------------------------------------------------
Snippet:
JW Pharmaceutical said Thursday it has secured exclusive domestic rights to bofanglutide, a next-generation GLP-1 receptor agonist, under a licensing agreement with China’s Gan & Lee Pharmaceuticals.
--------------------------------------------------------------------